MicroRNA-433 negatively regulates the expression of thymidylate synthase (TYMS) responsible for 5-fluorouracil sensitivity in HeLa cells

被引:54
作者
Gotanda, Keisuke [1 ]
Hirota, Takeshi [1 ]
Matsumoto, Nozomi [1 ]
Ieiri, Ichiro [1 ]
机构
[1] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacokinet, Higashi Ku, Fukuoka 8128582, Japan
关键词
MicroRNAs; miR-433; Thymidylate synthase; Fluorouracil; COLORECTAL-CANCER PATIENTS; MESSENGER-RNA; DIHYDROPYRIMIDINE DEHYDROGENASE; GASTRIC-CARCINOMA; DOSE ADJUSTMENT; GENE; RESISTANCE; POLYMORPHISM; CHEMOTHERAPY; 5-FU;
D O I
10.1186/1471-2407-13-369
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Thymidylate synthase (TYMS) is an important folate-dependent enzyme in DNA synthesis and an important target for cancer chemotherapy. High TYMS expression levels in tumors are generally associated with resistance to 5-fluorouracil (5-FU). The cause of the variability in TYMS expression is still not fully understood, however, only a small proportion of the TYMS expression can be explained by TYMS genetic polymorphisms. The purpose of this study is to identify novel microRNAs (miRNAs) which regulate the expression of TYMS and to determine whether miRNAs binding to the 3'-untranslated region (UTR) of TYMS mRNA affect the proliferation of HeLa cells treated with 5-FU. Methods: An in silico search was performed to find potential binding sites of miRNAs in TYMS mRNA. The efficacy of predicted miRNAs at the 3'-UTR of TYMS mRNA was evaluated using a dual-luciferase reporter assay. TYMS mRNA and protein expression in HeLa cells was quantified with real-time RT-PCR and Western blotting, respectively. The effects of miR-433 on cell proliferative activity were determined by WST-8 assay. Results: The overexpression of miR-433 was associated with significantly decreased reporter activity in the plasmid containing the 3'-UTR of TYMS mRNA (P < 0.01). The levels of TYMS mRNA and protein in HeLa cells were significantly decreased by the overexpression of miR-433 (P < 0.05). Furthermore, miR-433 increased inhibition of cell proliferation in HeLa cells treated with 5-FU at over 2.0 mu M. Conclusion: The results indicate that miR-433 post-transcriptionally regulates the expression of TYMS mRNA and protein, and increases sensitivity to 5-FU in HeLa cells. This is the first report showing that a miRNA regulating TYMS expression has a significant impact on sensitivity to 5-FU treatment.
引用
收藏
页数:8
相关论文
共 36 条
[1]  
Afzal S, 2011, PHARMACOGENOMICS, V12, P1257, DOI [10.2217/PGS.11.83, 10.2217/pgs.11.83]
[2]   Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line [J].
Bai, Haitao ;
Xu, Rang ;
Cao, Zhongwei ;
Wei, Daolin ;
Wang, Chun .
FEBS LETTERS, 2011, 585 (02) :402-408
[3]   miR-192/miR-215 Influence 5-Fluorouracil Resistance through Cell Cycle-Mediated Mechanisms Complementary to Its Post-transcriptional Thymidilate Synthase Regulation [J].
Boni, Valentina ;
Bitarte, Nerea ;
Cristobal, Ion ;
Zarate, Ruth ;
Rodriguez, Javier ;
Maiello, Evaristo ;
Garcia-Foncillas, Jesus ;
Bandres, Eva .
MOLECULAR CANCER THERAPEUTICS, 2010, 9 (08) :2265-2275
[4]   Thymidylate synthase (TYMS) and dihydropyrimidine dehydrogenase (DPYD) polymorphisms in the Korean population for prediction of 5-fluorouracil-associated toxicity [J].
Cho, Hyun-Jung ;
Park, Young Suk ;
Kang, Won Ki ;
Kim, Jong-Won ;
Lee, Soo-Youn .
THERAPEUTIC DRUG MONITORING, 2007, 29 (02) :190-196
[5]   THYMIDYLATE SYNTHASE GENE AMPLIFICATION IN HUMAN COLON-CANCER CELL-LINES RESISTANT TO 5-FLUOROURACIL [J].
COPUR, S ;
AIBA, K ;
DRAKE, JC ;
ALLEGRA, CJ ;
CHU, E .
BIOCHEMICAL PHARMACOLOGY, 1995, 49 (10) :1419-1426
[6]   THYMIDYLATE SYNTHETASE - TARGET ENZYME IN CANCER CHEMOTHERAPY [J].
DANENBERG, PV .
BIOCHIMICA ET BIOPHYSICA ACTA, 1977, 473 (02) :73-92
[7]   Combining Small Interfering RNAs Targeting Thymidylate Synthase and Thymidine Kinase 1 or 2 Sensitizes Human Tumor Cells to 5-Fluorodeoxyuridine and Pemetrexed [J].
Di Cresce, C. ;
Figueredo, R. ;
Ferguson, P. J. ;
Vincent, M. D. ;
Koropatnick, J. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 338 (03) :952-963
[8]   TS gene polymorphisms are not good markers of response to 5-FU therapy in stage III colon cancer patients [J].
Farina-Sarasqueta, A. ;
Gosens, M. J. E. M. ;
Moerland, E. ;
van Lijnschoten, I. ;
Lemmens, V. E. P. P. ;
Slooter, G. D. ;
Rutten, H. J. T. ;
van den Brule, Adriaan J. C. .
CELLULAR ONCOLOGY, 2011, 34 (04) :327-335
[9]  
Gamelin EC, 1996, CANCER, V77, P441, DOI 10.1002/(SICI)1097-0142(19960201)77:3<441::AID-CNCR4>3.0.CO
[10]  
2-N